School of Dietetics and Human Nutrition, McGill University, Ste-Anne-de-Bellevue, Québec, Canada
ActiGraph's Response to Novel Coronavirus (COVID-19) - July 30th Update
Adiposity and glucose intolerance exacerbate components of metabolic syndrome in children consuming sugar-sweetened beverages: QUALITY cohort study
- Published on Nov. 21, 2012
Background Sugar-sweetened beverage (SSB) consumption is linked to weight gain and metabolic syndrome (MetS) components in children, but whether these associations are modified by excess weight and glucose tolerance status in children is not known.
Objective The objective of this study was to examine the cross-sectional associations between SSB intake and MetS components among children above and below the 85th body mass index (BMI) percentile and those with and without impaired glucose tolerance (IGT).
Methods Data were from the QUébec Adiposity and Lifestyle InvesTigation in Youth study (2005–2008). Caucasian children aged 8–10 years (n = 632) were recruited from 1040 primary schools in Québec, Canada. SSB consumption was assessed by three 24-h dietary recalls, body fat mass by dual-energy absorptiometry, physical activity by 7-d accelerometer. Multivariate linear regressions were used, with age, sex, fat mass index and physical activity as covariates, including waist circumference (WC), systolic blood pressure (SBP), concentrations of triglyceride and high-density lipoprotein cholesterol and homeostasis model assessment of insulin resistance (HOMA-IR) as outcome variables.
Results Among overweight children, a 100-mL higher SSB consumption was associated with a 0.1-unit higher HOMA-IR (P = 0.009) and a 1.1-mm Hg higher SBP (P = 0.001). In children with IGT, a 100-mL higher SSB consumption was associated with a 1.4-mm Hg higher SBP and a 4.0-cm higher WC (P < 0.001). These associations were not observed among children <85th BMI percentile.
Conclusions Our results suggest that the association between higher SSB consumption and MetS components is more evident in overweight/obese and glucose-intolerant children.
- J. W. Wang 1
- S. Mark 2
- M. Henderson 3
- J. O'Loughlin 4
- A. Tremblay 5
- J. Wortman 6
- G. Paradis 3
- K. Gray-Donald 1, 3
First Nations & Inuit Health Branch, Health Canada, Vancouver, British-Columbia, Canada
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada
Département de Médecine Sociale et Préventive, Université de Montréal, Montréal, Québec, Canada
Division of Kinesiology, Faculty of Medicine, Université Laval, Québec, Quebec, Canada
Department of Family Practice, University of British Columbia, Vancouver, British-Columbia, Canada